M&A Pitch Book Project – Seoul

Glanbia PLC M&A Pitch Book

Project Background

Unilever recently announced its plan to grow fast-growing food business over the next 20-years. Unilever has shown strong interests in various food businesses, especially in active nutrition and well-being products. Correspondingly, we have decided to promote Glanbia PLC: health & wellness company with a strong brand awareness, as a target company. Therefore, acquiring Glanbia PLC will eventually allow Unilever to capture larger market share and achieve higher growth rate within the strikingly competitive food industry.

  • Part 1. Executive Summary
  • Part 2. Target Business Overview: Glanbia PLC
  • Part 3. Investment Highlights: Interpolar Analysis
  • Part 4. Target Industry Overview: The Global Active Nutrition Foods and Drinks
  • Part 5. Valuation Analysis: Overview and Valuation Football Field Chart

Project Leaders

So, Ha Young

Finance Project Member
FCB Finance Institute

Concentration Area: M&A Advisory

Yoo, Jun Young

Finance Project Member
FCB Finance Institute

Concentration Area: M&A Advisory

              Chang, Han Byul 

     Finance Project Member
FCB Finance Institute

                        Concentration Area: M&A Advisory

            Jung, Na Hyun 

     Finance Project Member
FCB Finance Institute

                        Concentration Area: M&A Advisory

        Lee, Soo Jin 

     Finance Project Member
FCB Finance Institute

                        Concentration Area: M&A Advisory

Finance Project Portfolio

Part 1.  Executive Summary

Glanbia PLC operates as a global nutrition company. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Joint Venture. The industry in which Glanbia’s products fall includes the functional food and sports nutrition market, which is projected to grow at a CAGR of 8% over 2018 – 2013. Glanbia PLC’s operating performance comparison between historical and projection period implies relatively lower enterprise value, EBITDA multiple, and share price. The two expected synergies between Unilever and Glanbia include revenue synergy and cost synergy.

CAGR stands for Compound Annual Growth Rate, and it is a measurement of growth over multiple time periods.
EBITDA stands for Earnings Before Tax, Depreciation and Amortization, and it measures a company’s operating performance.

Part 2.  Target Business Overview

As a global nutrition company, Glanbia PLC has established its market power within the sports nutrition market. Glanbia not only strengthened its product portfolio internally, but also has grown its segments through active acquisition deals. Glanbia seeks to grow its business targeting the APAC market, due to the growing demand of nutritional products within the region. Currently, 72% of Glanbia’s sales come from the U.S., and the rest are from Europe, Australia, and other region. Glanbia’s two segments, Glanbia Performance Nutrition and Glanbia Nutritionals counts for portion of sales of 53% and 47%, respectively. Glanbia Co-operative Society holds the largest share of 31% among the top 5 shareholders.

The difference between GPN and GN is that GPN focuses on sports so that it produces supplements to reduce muscle loss-rate pre-post exercise by providing a variety of types protein based on whey. GN is targeting consumers in a wide range of fields as well as sports by providing nutritional solutions.

Part 3.  Investment Highlights – Interloper Analysis

Glanbia PLC’s interlopers were selected based on the size of the market capitals and their investment interest toward healthcare nutrition and dairy products. For instances, Nestle announced to diversify its product portfolio by focusing on infants products and nutrition health, Danone has announced extension plans in the health-food-drinks segments, and Coca Cola started to invest on nutritional and functional beverages due to decreased revenue from carbonated drinks. General Mills established venturing arm – 301 INC that recently led $40m USD in plant-based food and beverage brand.

Debt/Equity Ratio is used to measure a company’s financial leverage; which indicates the amount of debt the company is using to finance its assets relative to the value of shareholders’ equity.
EBIT/Interest expenses ratio is used to measure debt and profitability; which indicates the ability of a company to pay interest on its outstanding debt.
Net debt/EBITDA ratio is used to measure a company’s financial leverage; which indicates the number of years a company would take to pay its debt back.

Part 4.  Target Industry Overview – The Global Active Nutrition Foods and Drinks

The global active nutrition foods and drinks market is a fast-growing market, which is expected to reach EUR 18 billion by 2022. The global active nutrition market is projected to make EUR 90 billion market, including three major segments: 1) consumer health 2) soft drinks 3) packaged food. Such an outstanding growth rate in global active nutrition market can be substantiated by different factors: 1) increasing demand for supplements & natural prevention 2) rising usage of snack-based meal replacements 3) growing consumer demand for greater ingredient traceability & authenticity. The global active nutrition industry encompasses various business segments such as consumer health, soft drinks, and packaged food. Sports nutrition, in particular, occupies EUR 26.7 billion in consumer health segment. Referring to the ‘Market Value of Sports Nutrition and Protein Products’ graph, sports protein powder accounts for the fastest growth in size within the products segment.

Part 5.  Valuation Analysis: Overview and Valuation Football Field Chart

Stock price performances of Glanbia PLC are relatively undervalued compared to those of other peer groups in behalf of three critical reasons: 1) Albeith of outstanding performances in the sports nutrition market, Glanbia`s product awareness in ACPC is rather weak compared to those of other regions such as US and Europe. 2) Glanbia Society announced to sell out Glanbia PLC`s share. 3) The growth rate of EV does not fully reflect the effect of the earnings.
In conclusion, the implied takeout price measured through valuation analyses is €5.9B – premium of 25.44%, share price of €18.48 per share.

Join a Finance Project

위와 같은 자신만의 금융권 포트폴리오를 만들고 싶으신가요? 이하의 국가별 파이낸스 프로젝트에 참여하셔서 본인의 금융권 커리어를 발전시키시길 바랍니다.

Legal Disclaimer

본 웹페이지에 명시된 디지털 자료는 대중에게 공개되어 있는 공적인 자료 (Public Information/Data)를 기반하여 학습 목적으로 모의로 재구성한 연습 자료 (case study) 로서, 실제 발생한 사건과 연관이 어떠한 경우도 없으며, 본질적으로 차이점을 가질 수 있으며, 작성자 또는 본 금융학회는 이를 바탕으로 어떠한 경제적인 이득을 취하지 않음을 알려드립니다. 이 자료를 바탕으로 금융학회의 동의 없이 사적 및 공적으로 의사 및 투자 결정을 하여도 어떠한 법적인 책임을 지지 않음을 알려드립니다. 이 자료를 학습 목적으로 사용을 원할시 본 금융학회의 서면 동의를 필요하며, 본 금융학회의 동의없이 자료를 금전적인 목적으로 사용을 하였을 시, 저작권법에 의해 법적인 책임을 지을 수 있습니다.  본 웹페이지에 공개된 자료를 기반하여 인재채용 심사 목적으로 자료 전체 열람을 원할시 info@fcbfi.org 로 문의바랍니다.

사업자번호: 107-19-79173 · 주소: 서울시 영등포구 국제금융로 20 · 통신판매업: 제2015-서울영등포-1572호 · 대표: 이혁재 · 개인정보관리자: 전신용 · 대표번호: 0507-1393-2118 · 고객문의: info@fcbfi.org · 이용약관 · 개인정보취급방침 COPYRIGHT(C)2021 FCBFI. ALL RIGHTS RESERVED.